Эта страница была переведена автоматически, точность перевода не гарантируется. Пожалуйста, обратитесь к английской версии для исходного текста.

Laparoscopic Ultrasound-Guided Removal of Multiple Uterine Fibroids

19 ноября 2026 г. обновлено: Hua Li

Laparoscopic Ultrasound-Guided Laparoscopic Myomectomy for Multiple Uterine Fibroids: A Prospective Randomized Controlled Trial

This study will examine whether ultrasound guidance during laparoscopic surgery can help surgeons remove uterine fibroids more completely. Uterine fibroids are noncancerous growths in the womb (uterus). Small fibroids or those deep in the uterine wall may be difficult to identify during surgery. Laparoscopic ultrasound uses a probe inside the abdomen to provide images of the uterus during the operation.

The study plans to enroll 110 premenopausal women aged 20 to 50 who have multiple uterine fibroids, need surgery, and wish to keep their uterus. Participants will be assigned by chance to laparoscopic ultrasound-guided myomectomy or conventional laparoscopic myomectomy, with 55 participants planned for each group. Myomectomy is surgery to remove fibroids while preserving the uterus.

The main outcome is the percentage of fibroids removed. For each participant, this is calculated by dividing the number of fibroids removed during surgery by the total number removed plus the number remaining on postoperative imaging, and multiplying by 100. Remaining fibroids will be assessed by transvaginal ultrasound or pelvic magnetic resonance imaging within 3 months after surgery.

Researchers will also assess the percentage of participants with remaining fibroids at 3 months, the difference between the number of fibroids removed and the number identified before surgery, surgical safety, postoperative recovery, and questionnaire scores related to sexual function, disability, anxiety, and quality of recovery. Follow-up visits are scheduled at 1, 3, and 12 months after surgery.

Обзор исследования

Подробное описание

Preoperative magnetic resonance imaging will be used to assess and count uterine fibroids. During laparoscopic ultrasound-guided myomectomy, the ultrasound probe will be placed in direct contact with the uterus to help locate fibroids and guide their removal. This approach is intended to improve identification of small or deep fibroids that may not be apparent on visual inspection. In both study groups, decisions about fibroid removal will be individualized, with clinical benefit and safety as the priorities.

Allocation will use stratified block randomization based on age, fibroid number, and maximum fibroid diameter, with a block size of four. A statistician who is not involved in recruitment or clinical intervention will generate the randomization sequence. Group assignments will be kept in sequentially numbered, sealed, opaque envelopes and revealed after completion of the baseline assessment and confirmation of enrollment.

Surgeons will be aware of treatment allocation. Outcome assessors and data analysts will remain blinded to group assignment.

Тип исследования

Интервенционный

Регистрация (Оцененный)

110

Фаза

  • Непригодный

Контакты и местонахождение

В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.

Контакты исследования

  • Имя: Xiali Xiong
  • Номер телефона: +86-13520418824
  • Электронная почта: xiongxiali2009@163.com

Места учебы

    • Beijing Municipality
      • Beijing, Beijing Municipality, Китай, 100024
        • Beijing Chao Yang Hospital, Capital Medical University
        • Контакт:
          • Xiali Xiong
          • Номер телефона: +86-13520418824
          • Электронная почта: xiongxiali2009@163.com

Критерии участия

Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.

Критерии приемлемости

Возраст, подходящий для обучения

От 20 лет до 50 лет (Взрослый)

Принимает здоровых добровольцев

Нет

Полы, имеющие право на обучение

Женский

Описание

Inclusion Criteria:

  • Symptomatic multiple uterine fibroids causing symptoms such as abnormal uterine bleeding, anemia, or pressure symptoms, with an indication for laparoscopic myomectomy and a desire to preserve the uterus.
  • Diagnosis established through clinical evaluation, preoperative transvaginal ultrasound, and magnetic resonance imaging (MRI), with MRI used for the final assessment and fibroid count.
  • Age 20 to 50 years and premenopausal, with or without future fertility plans.
  • No contraindications to laparoscopic surgery.

Exclusion Criteria:

  • Concomitant submucosal fibroids classified as FIGO types 0-2.
  • Findings suspicious for malignancy on preoperative assessment.
  • Uterine size equivalent to 20 weeks of gestation or greater; a history of pelvic inflammatory disease; severe endometriosis; grade III or IV uterine prolapse; or a history of intestinal obstruction, recurrent pelvic inflammatory disease, pelvic tuberculosis, or surgery for pelvic or abdominal tumors.
  • Known severe hepatic or renal dysfunction.
  • Known hematological disorders, bleeding or coagulation disorders, active bleeding at any site, or a bleeding tendency.
  • Severe central nervous system, cardiovascular, hepatic, renal, gastrointestinal, respiratory, endocrine or metabolic, musculoskeletal, or psychiatric disorders. Endocrine or metabolic disorders include thyroid disease, Cushing's syndrome, and hyperprolactinemia.
  • Acute infection.
  • Inability to sign the informed consent form.
  • Known or suspected poor adherence that would prevent completion of the study.

Учебный план

В этом разделе представлена ​​подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.

Как устроено исследование?

Детали дизайна

  • Основная цель: Уход
  • Распределение: Рандомизированный
  • Интервенционная модель: Параллельное назначение
  • Маскировка: Одинокий

Оружие и интервенции

Группа участников / Армия
Вмешательство/лечение
Экспериментальный: Laparoscopic Ultrasound-Guided Myomectomy

Participants will undergo laparoscopic myomectomy with intraoperative laparoscopic ultrasound guidance to locate uterine fibroids and assist their removal.

During laparoscopic myomectomy, a laparoscopic ultrasound probe will be placed in direct contact with the uterus to identify and localize fibroids and guide their removal. Fibroid removal will be individualized according to clinical benefit and safety.

Активный компаратор: Conventional Laparoscopic Myomectomy

Participants will undergo conventional laparoscopic myomectomy without intraoperative laparoscopic ultrasound guidance.

Uterine fibroids will be removed using conventional laparoscopic myomectomy without intraoperative laparoscopic ultrasound guidance. Fibroid removal will be individualized according to clinical benefit and safety.

Что измеряет исследование?

Первичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Fibroid Removal Rate
Временное ограничение: During surgery and within 3 months after surgery

For each participant, the fibroid removal rate is calculated as the number of fibroids removed during surgery divided by the sum of the number removed during surgery and the number of residual fibroids detected by postoperative transvaginal ultrasonography or pelvic magnetic resonance imaging, multiplied by 100.

During surgery and within 3 months after surgery

Вторичные показатели результатов

Мера результата
Мера Описание
Временное ограничение
Operative Time
Временное ограничение: During surgery

Duration of the surgical procedure, measured in minutes.

During surgery
Residual Uterine Fibroid Rate
Временное ограничение: 3 months after surgery (+/- 14 days)

Percentage of participants with at least one residual uterine fibroid detected by transvaginal ultrasonography or pelvic magnetic resonance imaging at the 3-month postoperative visit. The rate is calculated as the number of participants with residual fibroids divided by the total number who underwent surgery in each group, multiplied by 100.

3 months after surgery (+/- 14 days)
Difference Between Removed and Preoperatively Identified Fibroid Counts
Временное ограничение: Preoperative assessment and during surgery

For each participant, the difference is calculated as the number of fibroids removed during surgery minus the number identified on preoperative magnetic resonance imaging.

Preoperative assessment and during surgery
Estimated Intraoperative Blood Loss
Временное ограничение: During surgery

Estimated volume of blood lost during surgery, measured in milliliters.

During surgery
Participants With Intraoperative Complications
Временное ограничение: During surgery

Number of participants experiencing at least one intraoperative complication, including hematoma, ureteral injury, or neurovascular injury.

During surgery
Participants With Postoperative Complications
Временное ограничение: From completion of surgery through 12 months after surgery (final visit window: +/- 14 days)

Number of participants experiencing at least one postoperative complication, assessed during postoperative hospitalization and at scheduled follow-up visits.

From completion of surgery through 12 months after surgery (final visit window: +/- 14 days)
Postoperative Length of Hospital Stay
Временное ограничение: Perioperative

Time from completion of surgery to hospital discharge, measured in days.

Perioperative
Postoperative Pain Score
Временное ограничение: 2 and 6 hours after surgery

Postoperative pain intensity assessed using a visual analog scale at 2 and 6 hours after surgery. Higher scores indicate more severe pain.

2 and 6 hours after surgery
Time to First Postoperative Ambulation
Временное ограничение: Perioperative

Time from completion of surgery to first postoperative ambulation, measured in hours.

Perioperative
Time to First Postoperative Flatus
Временное ограничение: Perioperative

Time from completion of surgery to first passage of flatus, measured in hours.

Perioperative
Duration of Postoperative Uterotonic Treatment
Временное ограничение: Perioperative

Duration of postoperative uterotonic medication use, measured in hours.

Perioperative
Time to Postoperative Drain Removal
Временное ограничение: Perioperative

Time from completion of surgery to removal of the surgical drain, measured in hours, among participants with a drain placed.

Perioperative
Participants With Postoperative Urinary Dysfunction
Временное ограничение: 1, 3, and 12 months after surgery (each visit window: +/- 14 days)

Number of participants with postoperative urinary dysfunction, assessed at each scheduled follow-up visit.

1, 3, and 12 months after surgery (each visit window: +/- 14 days)
Participants With Postoperative Bowel Dysfunction
Временное ограничение: 1, 3, and 12 months after surgery (each visit window: +/- 14 days)

Number of participants with postoperative bowel dysfunction, assessed at each scheduled follow-up visit.

1, 3, and 12 months after surgery (each visit window: +/- 14 days)
Change From Baseline in Female Sexual Function Index Score
Временное ограничение: Baseline (before surgery), 3 months, and 12 months after surgery (postoperative visit windows: +/- 14 days)

Change from the preoperative baseline in the total Female Sexual Function Index score at each postoperative assessment. The questionnaire assesses sexual desire, arousal, lubrication, orgasm, satisfaction, and pain. Higher scores indicate better sexual function.

Baseline (before surgery), 3 months, and 12 months after surgery (postoperative visit windows: +/- 14 days)
Change From Baseline in Oswestry Disability Index Score
Временное ограничение: Baseline (before surgery), 1, 3, and 12 months after surgery (postoperative visit windows: +/- 14 days)

Change from the preoperative baseline in the Oswestry Disability Index score at each postoperative assessment. The questionnaire assesses disability associated with lower back or leg pain. Higher scores indicate greater disability.

Baseline (before surgery), 1, 3, and 12 months after surgery (postoperative visit windows: +/- 14 days)
Change From Baseline in Zung Self-Rating Anxiety Scale Score
Временное ограничение: Baseline (before surgery), within 48 hours after surgery, and 1, 3, and 12 months after surgery (monthly visit windows: +/- 14 days)

Change from the preoperative baseline in the Zung Self-Rating Anxiety Scale score at each postoperative assessment. The questionnaire contains 20 items assessing anxiety symptoms. Higher scores indicate more severe anxiety.

Baseline (before surgery), within 48 hours after surgery, and 1, 3, and 12 months after surgery (monthly visit windows: +/- 14 days)
15-Item Quality of Recovery Questionnaire Score
Временное ограничение: Within 48 hours after surgery and at 1, 3, and 12 months after surgery (monthly visit windows: +/- 14 days)

Total score on the 2025 Chinese version of the 15-item Quality of Recovery questionnaire at each postoperative assessment. Total scores range from 0 to 150, with higher scores indicating better quality of recovery. Changes between postoperative assessments will be evaluated.

Within 48 hours after surgery and at 1, 3, and 12 months after surgery (monthly visit windows: +/- 14 days)

Соавторы и исследователи

Здесь вы найдете людей и организации, участвующие в этом исследовании.

Спонсор

Даты записи исследования

Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.

Изучение основных дат

Начало исследования (Оцененный)

1 ноября 2026 г.

Первичное завершение (Оцененный)

1 января 2029 г.

Завершение исследования (Оцененный)

1 декабря 2029 г.

Даты регистрации исследования

Первый отправленный

28 октября 2026 г.

Впервые представлено, что соответствует критериям контроля качества

19 ноября 2026 г.

Первый опубликованный (Действительный)

20 ноября 2026 г.

Обновления учебных записей

Последнее опубликованное обновление (Действительный)

20 ноября 2026 г.

Последнее отправленное обновление, отвечающее критериям контроля качества

19 ноября 2026 г.

Последняя проверка

1 октября 2026 г.

Дополнительная информация

Термины, связанные с этим исследованием

Планирование данных отдельных участников (IPD)

Планируете делиться данными об отдельных участниках (IPD)?

НЕТ

Описание плана IPD

There is no plan to share de-identified individual participant data with researchers outside the study team.

Информация о лекарствах и устройствах, исследовательские документы

Изучает лекарственный продукт, регулируемый FDA США.

Нет

Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.

Нет

Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .

Подписаться